Trending Tickers: JA Solar Holdings (NASDAQ:JASO), Wells Fargo & Company (NYSE:WFC), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Cigna Corp. (NYSE:CI), Leucadia National (NYSE:LUK)

JA Solar Holdings Co., Ltd. (NASDAQ:JASO) announced that it will hold a conference call on Tuesday, August 11, 2015, at 8:00 a.m. U.S. Eastern Time (8:00 p.m.Beijing/Hong Kong Time), to discuss the Company’s second quarter 2015 results. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) belongs to Technology sector. Its net profit margin is 4.00% and weekly performance is -2.35%. On last trading day company shares ended up $7.49. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) distance from 50-day simple moving average (SMA50) is -8.91%.

Wells Fargo & Company (NYSE:WFC) announces that it has entered into an agreement to offer Financial Engines’ suite of institutional retirement planning solutions to companies with 401(k) plans recordkept by Wells Fargo. As the nation’s largest independent registered investment advisor1, Financial Engines is the leader in providing high-quality advisory services to retirement plan participants. Wells Fargo anticipates a release date of mid-2016, at which time retirement plan sponsors on the Wells Fargo recordkeeping platform can elect to add this expanded offering to their retirement benefit plans to help participants make the most out of their retirement savings. Wells Fargo & Company (NYSE:WFC) shares fell -0.29% in last trading session and ended the day at $57.65. Its return on assets is 1.30%. Wells Fargo & Company (NYSE:WFC) quarterly performance is 4.97%.

On 05 August, La Jolla Pharmaceutical Co. (NASDAQ:LJPC) announced that it has signed two exclusive worldwide license agreements for the intellectual property rights covering La Jolla’s next-generation gentamicin derivatives, LJPC-30Sa and LJPC-30Sb. The first license agreement is with the Indiana University Research and Technology Corporation (IURTC), and the second is with the IURTC and the University of Alabama at Birmingham (UAB). The license agreements, which follow from the previously announced option agreements, cover the use of LJPC-30Sa and LJPC-30Sb as antimicrobial agents and for the potential treatment of rare genetic disorders. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) shares advanced 3.94% and was closed at $30.62. LJPC EPS growth in last 5 year was 0.00%. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) year to date (YTD) performance is 65.96%.

Cigna Corp. (NYSE:CI) and Virginia Cancer Institute have started a program that aims to enhance care for people receiving chemotherapy to treat any type of cancer. Cigna Corp. (NYSE:CI) ended the last trading day at $147.55. Company weekly volatility is calculated as 1.91% and price to cash ratio as 19.30. Cigna Corp. (NYSE:CI) showed a weekly performance of 1.47%.

Leucadia National Corporation (NYSE:LUK) said the value of its bailout loan to online currency-trading firm FXCM Inc. declined by more than $100 million even as the firm more than doubled its money on the deal. Leucadia National Corporation (NYSE:LUK) shares fell -1.16% in last trading session and ended the day at $23.04. LUK Gross Margin is 31.80% and its return on assets is 1.10%. Leucadia National Corporation (NYSE:LUK) quarterly performance is -1.66%.

Leave a Reply

Your email address will not be published. Required fields are marked *